Bone windows for distinguishing malignant from benign primary bone tumors on FDG PET/CT

Journal of Cancer

Volumn 4, Issue 7, 2013, Pages 524-530

  Costelloe, Colleen M ^a   Chuang, Hubert H ^a   Chasen, Beth A ^a   Pan, Tinsu ^a   Fox, Patricia S ^a   Bassett, Roland L ^a   Madewell, John E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bone window; CT; FDG PET CT; Primary bone tumor; Soft tissue window

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; BENIGN TUMOR; BONE BIOPSY; BONE TUMOR; CANCER DIAGNOSIS; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER TOMOGRAPHY SCANNER; ENCHONDROMA; EWING SARCOMA; FIBROMA; FIBROUS DYSPLASIA; FOLLOW UP; GIANT CELL TUMOR; GRANULOMA; HEMANGIOMA; HUMAN; IMAGING; LANGERHANS CELL HISTIOCYTOSIS; LIPOMA; MAJOR CLINICAL STUDY; OSTEOCHONDROMA; OSTEOCLASTOMA; OSTEOSARCOMA; PRIMARY TUMOR; RADIOLOGIST; REFERENCE DATABASE; SARCOMA; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

EID: 84882955300     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.6259     Document Type: Article

References (26)

1. Becker H, Norman D, Boyd DP, Hattner RS, Newton TH. Computed tomography in detecting calvarial metastases: a comparison with skull radiography and radionuclide scanning. Neuroradiology. 1978; 16:504-505.
2. [Internet] University of South Carolina. Digital Imaging. http://radiology.med.sc.edu/6digimg.html.
3. Tecce PM, Fishman EK. Spiral CT with multiplanar reconstruction in the diagnosis of sternoclavicular osteomyelitis. Skeletal Radiol. 1995; 24(4):275-281.
4. Kashiwagi N, Hirabuki N, Andou K, Yoshifumi N, Tanaka H, Morino H, et al. MRI and CT findings of the giant cell tumors of the skull; five cases and a review of the literature. Eur J Radiol. 2006; 58(3):435-443.
5. Laval-Jeantet M, Paxton L, Frija J, Preteux F. Observer variation in bone lesion detection in thoraco-abdominal visceral CT images. Eur J Radiol. 1985; 5(4):310-312.
6. Pomerantz SM, White CS, Krebs TL, Daly B, Sukumar SA, Hooper F, et al. Liver and bone window settings for soft-copy interpretation of chest and abdominal CT. AJR Am J Roentgenol. 2000; 174(2):311-314.
7. Herrlin K, Ekelund L, Lovdahl R, Persson B. Computed tomography in suspected osteoid osteomas of tubular bones. Skeletal Radiol. 1982; 9(2):92-97.
8. Vandemark RM, Shpall EJ, Affronti ML. Bone metastases from breast cancer: value of CT bone windows. J Comput Assist Tomogr. 1992; 16(4):608-614.
9. Avila NA, Dwyer AJ, Rabel A, Darling T, Hong CH, Moss J. CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis. Radiology. 2010; 254(3):851-857.
10. Salvati M, Ciappetta P, Raco A. Osteosarcomas of the skull. Clinical remarks on 19 cases. Cancer. 1993; 71(7):2210-2216.
11. Avrahami E, Even I. Osteoma of the inner table of the skull--CT diagnosis. Clin Radiol. 2000; 55(6):435-438.
12. Ryan JT, Haygood TM, Yamal JM, Evanoff M, O'Sullivan P, McEntee M, et al. The "memory effect" for repeated radiologic observations. AJR Am J Roentgenol. 2011; 197(6):W985-991.
13. Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006; 47(6):1059-1066.
14. Dehdashti F, Siegel BA, Griffeth LK, Fusselman MJ, Trask DD, McGuire AH, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology. 1996; 200(1):243-247.
15. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001; 219(3):774-777.
16. Kole AC, Nieweg OE, Hoekstra HJ, van Horn JR, Koops HS, Vaalburg W. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med. 1998; 39(5):810-815.
17. Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med. 2000; 41(10):1695-1701.
18. Feldman F, Van Heertum R, Saxena C, Parisien M. 18FDG-PET applications for cartilage neoplasms. Skeletal Radiol. 2005; 34(7):367-374.
19. Strobel K, Exner UE, Stumpe KD, Hany TF, Bode B, Mende K, et al. The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT. Eur J Nucl Med Mol Imaging. 2008; 35(11):2000-2008.
20. Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging. 2004; 31(2):189-195.
21. Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr. 1999; 23(4):603-608.
22. Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors. Annals of nuclear medicine. 2008; 22(7):603-609.
23. Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissuesarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging. 2009; 36(12):1944-1951.
24. Costelloe CM, Madewell J. Radiography in the Initial Diagnosis of Primary Bone Tumors. AJR Am J Roentgenol. 2013; 200(1):3-7.
25. Madewell JE, Ragsdale BD, Sweet DE. Radiologic and pathologic analysis of solitary bone lesions. Part I: internal margins. Radiol Clin North Am. 1981; 19(4):715-748.
26. Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009; 10(6):606-614.